Altre lingue Embla Medical hf.

Azioni

Tempo reale stimato Cboe Europe Altri mercati azionari 15:40:33 18/04/2024			Variaz. 5gg	Var. 1 gen.
29,7 ^DKK	-2,30%		-1,33%	+7,83%

13/03	Össur hf. nomina Caroline Vagner Rosenstand nel Comitato di revisione contabile	CI
21/02	Össur hf crea una nuova organizzazione madre che prenderà il nome di Embla Medical	CI

Össur hf. will Change its Name to Embla Medical hf	08/04
Össur hf: Board Decisions Following the Annual General Meeting	13/03
Össur hf. Appoints Caroline Vagner Rosenstand to the Audit Committee	13/03
Össur hf: Results of the Annual General Meeting	13/03
Össur hf: Candidates to the Board of Directors	10/03
Össur hf: Final Agenda and Proposals for the Annual General Meeting 13 March 2024	28/02
Össur hf: Össur establishes new parent organization to be named Embla Medical	21/02
Össur hf Establishes New Parent Organization to Be Named Embla Medical	21/02
Össur hf: Annual General Meeting 13 March 2024	21/02
Össur hf: Annual Report 2023	30/01
Össur hf: Interim Report Q4 2023	30/01
Össur hf. Reports Earnings Results for the Full Year Ended December 31, 2023	30/01
Össur hf. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	30/01
Össur hf. Provides Earnings Guidance for the Year 2024	30/01
Össur hf: Össur's total share capital following completion of capital increase of 6,636,122 shares	24/01
Iceland's Össur to Purchase Fior & Gentz	16/01
Össur hf: Össur acquires FIOR & GENTZ	16/01
Össur hf. agreed to acquire Fior & Gentz Gesellschaft Für Entwicklung Und Vertrieb Von Orthopädietechnischen Systemen Mbh for ?120 million.	16/01
Össur hf: Financial Calendar 2024	20/12
Össur hf: Major Shareholder Announcement	21/11

Non ci sono risultati per questa ricerca